Hangzhou Coco Healthcare Products Co Ltd
SZSE:301009
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hangzhou Coco Healthcare Products Co Ltd
SZSE:301009
|
CN |
|
M
|
MUI Properties Bhd
KLSE:MUIPROP
|
MY |
|
Coda Octopus Group Inc
NASDAQ:CODA
|
US |
|
G
|
Guangdong Rongtai Industry Co Ltd
SSE:600589
|
CN |
|
P
|
Pinar Su ve Icecek Sanayi ve Ticaret AS
IST:PINSU.E
|
TR |
|
Bastei Luebbe AG
XETRA:BST
|
DE |
|
Capitaland Investment Ltd
OTC:CLILF
|
SG |
|
Care REIT PLC
LSE:CRT
|
UK |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
US |
|
Cavitation Technologies Inc
OTC:CVAT
|
US |
|
DFS Furniture PLC
LSE:DFS
|
UK |
|
M
|
Malaysian Bulk Carriers Bhd
KLSE:MAYBULK
|
MY |
|
Nedap NV
AEX:NEDAP
|
NL |
|
PRT Company Ltd
ASX:PRT
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hangzhou Coco Healthcare Products Co Ltd's stock price target?
Not Available
Hangzhou Coco Healthcare Products Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hangzhou Coco Healthcare Products Co Ltd's Revenue forecast?
Projected CAGR
69%
For the last 5 years the
compound annual growth rate for
Hangzhou Coco Healthcare Products Co Ltd's revenue is
-2%.
The projected
CAGR
for the next 1 year is
69%.
What is Hangzhou Coco Healthcare Products Co Ltd's Net Income forecast?
Projected CAGR
420%
For the last 5 years the
compound annual growth rate for
Hangzhou Coco Healthcare Products Co Ltd's net income is
-19%.
The projected
CAGR
for the next 1 year is
420%.
